Ad is loading...
AZMAX
Price
$15.75
Change
-$0.14 (-0.88%)
Updated
Nov 15 closing price
RNWFX
Price
$80.56
Change
-$0.79 (-0.97%)
Updated
Nov 15 closing price
Ad is loading...

AZMAX vs RNWFX

Header iconAZMAX vs RNWFX Comparison
Open Charts AZMAX vs RNWFXBanner chart's image
Virtus NFJ Emerging Markets Value A
Price$15.75
Change-$0.14 (-0.88%)
VolumeN/A
CapitalizationN/A
American Funds New World R5
Price$80.56
Change-$0.79 (-0.97%)
VolumeN/A
CapitalizationN/A
AZMAX vs RNWFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
AZMAX vs. RNWFX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AZMAX is a Buy and RNWFX is a Buy.

FUNDAMENTALS
Fundamentals
RNWFX has more cash in the bank: 60.9B vs. AZMAX (17.1M). RNWFX (1.51) and AZMAX (1.47) have matching dividends . AZMAX was incepted earlier than RNWFX: AZMAX (12 years) vs RNWFX (23 years). AZMAX is a more actively managed with annual turnover of: 92.00 vs. RNWFX (32.00). RNWFX has a lower initial minimum investment than AZMAX: RNWFX (250) vs AZMAX (2500). RNWFX annual gain was more profitable for investors over the last year : 11.54 vs. AZMAX (2.90). RNWFX return over 5 years is better than : 17.17 vs. AZMAX (2.80).
AZMAXRNWFXAZMAX / RNWFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence12 years23 years-
Gain YTD0.8577.09912%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets17.1M60.9B0%
Annual Yield % from dividends1.471.5197%
Returns for 1 year2.9011.5425%
Returns for 3 years-24.58-14.55169%
Returns for 5 years2.8017.1716%
Returns for 10 years15.6641.0038%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VRNA35.660.29
+0.82%
Verona Pharma plc
BURL268.94-0.65
-0.24%
Burlington Stores
RCMT22.25-0.38
-1.68%
RCM Technologies
SNTI2.15-0.18
-7.73%
Senti Biosciences Inc.
CATX7.88-1.04
-11.66%
Perspective Therapeutics